Inventor · disambiguated record
Ellen Puré
Also filed as: PURE ELLEN · PURÉ ELLEN
6 granted patents·4 pending applications·58 citations·filing 2013–2024
77Inventor score
Files withUNIV PENNSYLVANIA10
Top patents by PatentIndex Score
10 records- 0195US9365641B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Jun 14, 2016·54 cites·26 claims
- 0286US11786551B2Methods for treating heart disease via redirected T cell immunotherapiesUNIV PENNSYLVANIA·Filed 2018·Granted Oct 17, 2023·4 cites·11 claims
- 0379US2023416408A1Compositions and Methods for Targeting Stromal Cells for the Treatment of CancerUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0473US11718685B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2019·Granted Aug 8, 2023·0 cites·8 claims
- 0571US2024384004A1Monoclonal Antibody Against Canine Fibroblast Activation Protein that Cross-Reacts with Mouse and Human Fibroblast Activation Protein (FAP)UNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0668US2024016848A1Compositions and Methods for Treating Heart Disease via Redirected T Cell ImmunotherapiesUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0764US2025011472A1Disrupting tumor tissues by targeting fibroblast activation protein (fap)UNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0861US12139550B2Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP)UNIV PENNSYLVANIA·Filed 2020·Granted Nov 12, 2024·0 cites·11 claims
- 0958US10329355B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jun 25, 2019·0 cites·9 claims
- 1053US12116418B2Disrupting tumor tissues by targeting fibroblast activation protein (FAP)UNIV PENNSYLVANIA·Filed 2020·Granted Oct 15, 2024·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Ellen Puré files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →